EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence

Donovan Worrall iD, Riham Ayoubi, Maryam Fotouhi, Kathleen Southern iD, Peter S McPherson, Carl Laflamme iD, NeuroSGC/YCharOS/EDDU collaborative group, ABIF Consortium

F1000Research · 20.06.2023 · 12 · 277

DOI: 10.12688/f1000research.131852.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 20.06.2023. Verfasst von Donovan Worrall und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H…. Hauptthemen laut MEDLINE: DNA-Binding Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Motor Neurone Disease Association, Mitacs, ALS Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TAR DNA-binding protein 43 (TDP-43) is a DNA/RNA binding protein playing a critical role in the regulation of transcription, splicing and RNA stability. Mutations in TARDBP leading to aggregation, are suspected to be a characteristic feature of various neurogenerative diseases. The lack of well-characterized anti- TDP-43 antibodies acts as a barrier to establish reproducible TDP-43 research. In this study, we characterized eighteen TDP-43 commercial antibodies for Western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many well-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA-Binding ProteinsCell LineBlotting, WesternFluorescent Antibody TechniqueImmunoprecipitation

Stichwörter der Autor:innen

TARDBPTDP-43Uniprot ID Q13148Western Blotantibody characterizationantibody validationimmunofluorescenceimmunoprecipitation

Substanzen

DNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.

ORCID-Profile: Donovan Worrall, Kathleen Southern, Carl Laflamme

Förderung

  • Motor Neurone Disease Association
  • Mitacs
  • ALS Association
  • Genome Canada
  • ALS Society of Canada
  • Canadian Institutes of Health Research Foundation
  • Ontario Genomics
  • Genome Quebec

Zitieren

APA

Worrall, D., Ayoubi, R., Fotouhi, M., Southern, K., McPherson, P. S., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF Consortium (2023). The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research, 12, 277. https://doi.org/10.12688/f1000research.131852.2

Vancouver

Worrall D, Ayoubi R, Fotouhi M, Southern K, McPherson PS, Laflamme C, et al. The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence. F1000Research. 2023;12:277. doi:10.12688/f1000research.131852.2

BibTeX
@article{Worrall2023,
  author = {Worrall, Donovan and Ayoubi, Riham and Fotouhi, Maryam and Southern, Kathleen and McPherson, Peter S and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF Consortium, ABIF Consortium},
  title = {The identification of high-performing antibodies for TDP-43 for use in Western Blot, immunoprecipitation and immunofluorescence},
  journal = {F1000Research},
  year = {2023},
  volume = {12},
  pages = {277},
  doi = {10.12688/f1000research.131852.2}
}
Kostenlos starten →